Clinical Trial Update: A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating safety and tolerability of cobimetinib plus GDC-0994 in patients with various advanced solid tumors, including non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Melanoma
• Non Small Cell Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Cobimetinib (cobimetinib)
• GDC-0994

Snippet

Sponsor: Genentech, Inc. | Conditions: Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Cancers, Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2018-08-24